VTv Current Deferred Revenue from 2010 to 2024
| VTVT Stock | USD 16.04 0.53 3.42% |
Current Deferred Revenue | First Reported 2014-12-31 | Previous Quarter 17 K | Current Value 17 K | Quarterly Volatility 3.7 M |
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 27.56, Dividend Yield of 0.0 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
VTv | Current Deferred Revenue |
Latest VTv Therapeutics' Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of vTv Therapeutics over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. VTv Therapeutics' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
VTv Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 949,122 | |
| Geometric Mean | 115,635 | |
| Coefficient Of Variation | 242.54 | |
| Mean Deviation | 1,394,351 | |
| Median | 137,000 | |
| Standard Deviation | 2,301,972 | |
| Sample Variance | 5.3T | |
| Range | 8.7M | |
| R-Value | (0.07) | |
| Mean Square Error | 5.7T | |
| R-Squared | 0 | |
| Significance | 0.81 | |
| Slope | (34,055) | |
| Total Sum of Squares | 74.2T |
VTv Current Deferred Revenue History
About VTv Therapeutics Financial Statements
VTv Therapeutics shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 15.3 K | 14.5 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VTv Stock Analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.